Regeneron Pharmaceuticals
REGN
#227
Rank
S$110.10 B
Marketcap
$1,002
Share price
0.43%
Change (1 day)
-6.56%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2023 (TTM): $50.37

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $50.14. In 2022 the company made an earnings per share (EPS) of $54.38 a decrease over its 2021 EPS that were of $102.60.

EPS history for Regeneron Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$50.37-7.37%
2022$54.38-47%
2021$102.60133.36%
2020$43.9769.13%
2019$26.00-14.44%
2018$30.38100.71%
2017$15.1431.78%
2016$11.4938.96%
2015$8.2772.55%
2014$4.79-17.55%
2013$5.81-44.98%
2012$10.56-422.54%
2011-$3.2792.13%
2010-$1.7049.41%
2009-$1.14-15.84%
2008-$1.36-36.88%
2007-$2.15-9.6%
2006-$2.384.12%
2005-$2.28-323.68%
2004$1.02-135.51%
2003-$2.87-24.38%
2002-$3.8056.35%
2001-$2.43187.3%
2000-$0.85-16%
1999-$1.01177.78%
1998-$0.36-35.71%
1997-$0.56-68.42%
1996-$1.78

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$18.99-62.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.52-111.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$24.77-50.59%๐Ÿ‡บ๐Ÿ‡ธ USA
$18.90-62.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.02-89.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$4.27-91.49%๐Ÿ‡ซ๐Ÿ‡ท France